Skip to main content
Xlife Sciences AG logo

Xlife Sciences AG — Investor Relations & Filings

Ticker · XLS ISIN · CH0461929603 LEI · 984500AH590BE88BB517 SW Professional, scientific and technical activities
Open in API
Filings indexed 287 across all filing types
Latest filing 2023-09-29 Environmental & Social …
Country CH Switzerland
Listing SW XLS

About Xlife Sciences AG

https://www.xlifesciences.ch/en/home

Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.

Recent filings

Filing Released Lang Actions
ESG-Bericht zeigt Status Quo und skizziert den Weg für zukünftige Nachhaltigkeits-Verbesserungen Medienmitteilung Zürich, 29. September 2023
Environmental & Social Information Classification · 1% confidence The document is titled as a 'Medienmitteilung' (Media Release) and explicitly states that Xlife Sciences AG has 'veröffentlicht' (published) its initial report on Environment, Social, and Governance (ESG). The content focuses entirely on summarizing the findings and strategy outlined in this ESG report, mentioning KPIs, governance practices, and future plans related to sustainability. This clearly aligns with the definition of an Environmental & Social Information report (ESG report). Although it is an announcement of the report's publication, the document itself contains substantial detail about the report's contents, making it more than just a brief 'Report Publication Announcement' (RPA). Therefore, the most specific classification is 'Environmental & Social Information' (SR).
2023-09-29 German
Xlife Sciences with significant progress in H1 2023
Earnings Release Classification · 1% confidence The document is an 'Ad-hoc' announcement dated September 21, 2023, reporting on 'significant progress in H1 2023' and publishing 'key financial figures for the reporting period'. It explicitly mentions the 'full half-year report 2023 is available for download'. This structure—an announcement summarizing period results and pointing to the full report—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it covers the first half of the year (H1 2023) and provides key financial figures, it aligns best with the Interim/Quarterly Report category (IR). However, the text itself is an announcement summarizing the results and operational highlights, rather than the comprehensive report itself. Furthermore, the document explicitly states it is a 'Release of an ad hoc announcement pursuant to Art. 53 LR' and provides operational and financial highlights for H1 2023. This format, summarizing period results, strongly suggests an Earnings Release (ER) which is the initial announcement of periodical financial results. If it were the full report, it would likely be much longer and structured differently. Given the context of reporting H1 results and key figures, ER is the most appropriate classification for this announcement format, even though it references the full half-year report. H1 2023
2023-09-21 English
Xlife Sciences with significant progress in H1 2023
Earnings Release Classification · 1% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and explicitly states it reports on 'Key word(s): Half Year Results' and publishes 'key financial figures for the reporting period' (H1 2023). It provides operational highlights and financial key figures for the first half of the year, which is characteristic of an Interim/Quarterly Report (IR). However, the text also states: 'Xlife Sciences’ full half-year report 2023 is available for download as a PDF document at [link]...'. This structure—a brief announcement summarizing results and pointing to the full report—aligns perfectly with the definition of a Report Publication Announcement (RPA) according to Rule 2 (The 'MENU VS MEAL' Rule). The document length (7450 chars) is substantial but the primary function here is announcing the availability of the full report, not being the full report itself. Therefore, RPA is the most accurate classification. H1 2023
2023-09-21 English
Xlife Sciences mit signifikanten Fortschritten im 1. Halbjahr 2023
Earnings Release Classification · 1% confidence The document is titled 'Ad hoc-Mitteilung gemäss Art. 53 KR' (Ad hoc announcement according to Art. 53 KR) and explicitly states it is a 'Veröffentlichung einer Ad-hoc-Mitteilung' (Publication of an ad-hoc announcement). It reports on the '1. Halbjahr 2023' (First Half Year 2023) and provides key financial figures (Umsatzerlös, Ergebnis je Aktie, Bilanzsumme) and operational updates. This structure—a brief announcement summarizing period results and pointing to a full report—is characteristic of an Earnings Release (ER) or, given the comprehensive nature of the summary and the focus on a half-year period, an Interim/Quarterly Report (IR) announcement. Since it summarizes the financial performance for a period shorter than a year ('Halbjahresbericht 2023'), the core content relates to an Interim Report. However, the document itself is the *announcement* of these results, not the full, detailed report (which it links to). In many regulatory contexts, a press release summarizing period results is classified as an Earnings Release (ER). Given the content summarizes key financial highlights for the first half-year, ER is the most appropriate fit for the announcement itself, even though it references the full 'Halbjahresbericht'. If the document were the full report, it would be IR. As it is the announcement summarizing the period's results, ER is selected. The document length (9465 chars) is substantial but still functions as a summary announcement rather than the full statutory report. H1 2023
2023-09-21 German
Collaboration of Xlife Sciences and the Department of Health Abu Dhabi to drive global innovations in the life sciences sector
Regulatory Filings Classification · 1% confidence The document is explicitly labeled as an "Ad-hoc" announcement released pursuant to "Art. 53 LR" (Listing Rules), indicating it is a mandatory disclosure of price-sensitive information. The content details a strategic Memorandum of Understanding (MoU) signing between Xlife Sciences AG and the Department of Health – Abu Dhabi, involving strategic decisions, partnerships, and future plans. This type of material, which is not a full financial report (like 10-K or IR), a specific voting result (DVA), or a management change (MANG), falls best under the general category for significant regulatory disclosures that aren't covered by more specific codes. Since it is a significant, non-routine corporate announcement, and it is not a simple announcement of a report publication (RPA), the most appropriate general regulatory filing category is 'Regulatory Filings' (RNS), which serves as a catch-all for important, non-standard disclosures.
2023-08-17 English
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'Ad hoc announcement pursuant to Art. 53 LR' and is released via an 'EQS News Service'. It details a strategic Memorandum of Understanding (MoU) signing between Xlife Sciences AG and the Department of Health – Abu Dhabi, which is a significant, non-routine corporate event. This type of immediate, material information release, often mandated by listing rules (like Art. 53 LR in Switzerland), does not fit the definitions for standard periodic reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). It is a general regulatory disclosure of material non-public information. Since it is a specific, material announcement that doesn't fit the other specialized categories (like M&A, Management Change, or Dividend), the most appropriate classification is the general regulatory announcement fallback category, RNS (Regulatory Filings). The document length is moderate (6590 chars), but its nature is that of an immediate disclosure, not a report publication announcement (RPA) which typically just points to another document.
2023-08-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.